Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 73, Issue 3, 2002, Pages 261-266

  Liolitsa, D ^a   Powell, J ^a   Lovestone, S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGE FACTORS; AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; PHOSPHOPROTEIN PHOSPHATASE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0036724836     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.73.3.261     Document Type: Article

References (47)

1. Diabetes mellitus and the risk of dementia: The Rotterdam study
2. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross sectional population based study
3. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease
4. A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease
5. Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway
6. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons
7. The Camberwell dementia case register
8. Manchester and Oxford Universities scale for the psychopathological assessment of dementia (MOUSEPAD)
9. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia
10. Mini-metal state. A practical method for grading the cognitive state of patients for the clinician
11. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop
12. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
13. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
14. Prevalence of a polymorphism of the phosphatidylinositol 3-kinase p85 alpha regulatory subunit (codon 326 Met→lle) in Japanese NIDDM patients
15. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin
16. K variant of butyrycholinesterase and late-onset Alzheimer's disease
17. Type 2 diabetes mellitus, cognitive impairment and dementia
18. Neurologic complications of diabetes mellitus: Transient ischemic attacks, stroke and peripheral neuropathy
19. Type 2 diabetes and depressive symptoms in older adults: A population-based study
20. Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease
21. Relationship between hyperglycemia and cognitive function in older NIDDM patients
22. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment
23. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer's disease
24. Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris
25. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase
26. Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): Preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women
27. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype
28. Role of protein targeting to glycogen (PTG) in the regulation of protein phosphatase-1 activity
29. Variation in the AU(AT)-rich element within the 3′-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians
30. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons
31. Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein tau
32. A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes
33. Asp905Tyr polymorphism of the gene for the skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in NIDDM
34. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance
35. Type 2 Diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia aging study
36. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort
37. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales
38. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies
39. The phosphorylation of tau: A critical stage in neurodevelopmental and neurodegenerative processes
40. Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB
41. Starvation induces tau hyperphosphorylation in mouse brain: Implications for Alzheimer's disease
42. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling
43. Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention
44. Protective and rescuing abilities of IGF-I and some putative free radical scavengers against beta-amyloid-inducing toxicity in neurons
45. Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis
46. Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V6421 mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner
47. Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation